nQ in the News
November 2017: nQ Medical takes unanimous 1st place at the PRISME Forum AI Startup Contest.
Read Article: Business Insider
Everyone has a unique typing signature. Research has revealed that the way we interact with computers and mobile devices can reveal with startling accuracy the presence of certain neuro-motor diseases. This Massachusetts Institute of Technology discovered/Michael J. Fox Foundation validated artificial intelligence tool (neuroQWERTY) has opened a broad opportunity to better diagnose diseases, track disease progression, and monitor medication effectiveness and symptoms.
We’ve found rich information hidden in the way our fingers interact with smart devices, that allows for motor impairment tracking and potentially early detection of neurodegenerative disease onset.
Our algorithms detect the subtle psychomotor impairment typical of these diseases by analyzing the timing of keystrokes. No information of what you are typing is captured. No hardware changes required.
A Modern Neurological Disease Detection Platform
Addressing Real Clinical Trial challenges
- Better, faster identification of ideal study participants for fewer required subjects/bigger effect size
- Less in-clinic observation (at-home, unbiased, real-world data) improves compliance/saves money
- Passive/continuous monitoring yields earlier measure of drug impact and increased speed to FDA approval/market launch
An End-to-End Machine Learning Platform for the Entire Drug Development Lifecycle
For Pharma/Medical Device, Clinician, and Patient
Teresa Arroyo Gallego
Lead Data Scientist
At nQ, Dr. Arroyo-Gallego is responsible for overseeing and designing R&D activities and studies to validate and improve the nQ technology. She is also a Visiting Scholar at the Massachusetts Institute of Technology (MIT), where she continues to work on research activities to evaluate and explore new areas of machine learning application.
Dr. Arroyo-Gallego is a computer scientist and biomedical engineer with a research focus on the application of artificial intelligence to develop innovative solutions for healthcare problems. In the early years of her scientific career, she worked in different biomedical research groups what allowed her to further develop her technical skills and provided her an excellent experience and understanding of the multidisciplinary environment in the biomedical engineering world. These experiences confirmed her passion and commitment to dedicate her career to improve people’s health.
DAVID KREUTTER, PH.D., PFIZER, KREUTTER LIFE SCIENCES LLC | DAVID LEE SCHER, MD, CARDIOLOGIST, DIGITAL HEALTH CONSULTANT | MARK PASCARELLA, MBA, INVESTOR, FOUNDERS WANTED, ZOLTAN MARI, MD, Chief, Movement Disorder Program, The Cleveland Clinic Lou Ruvo Center for Brain Health | Naomi Fried, CEO, Health Innovation Strategies
Interested in learning more about nQ Medical? Send us a message and let us know how we can help.